Private equity firms’ pullback from some corners of the healthcare industry has been outpacing the slowdown in other sectors, PitchBook data shows.
In healthcare services and health-focused IT sectors, the number of deals reached fresh lows in Q2—down more than 70% from peak dealmaking times in the fourth and second quarters of 2021, respectively, according to our Q2 Healthcare Services and Healthcare IT reports.
By contrast, PE dealmaking in the broader market across all sectors has fallen by an estimated 29% from its high in Q4 2021—a deep drop but a significantly lower one.
In a wide range of industries, deal-making has been constrained amid a persistent disconnect over valuations.
But in healthcare services, steeper debt-servicing costs have also put a squeeze on highly leveraged practices specializing in dental, vision or veterinary care, restricting their ability to do add-on deals, which have represented an outsized portion of broader PE dealmaking.
The buyer-seller disconnect contributed to the April dissolution of Carlyle’s plan to acquire a stake in healthcare analytics provider Cotiviti from Veritas Capital, a deal that would have valued the company around $15 billion, including debt. That failed deal “set the tone for a quarter of muted deal activity,” PitchBook lead sector analyst Rebecca Springer wrote.
Within the healthcare IT sector, the pace of corporate mergers and acquisitions has slowed even more than PE deals, according to PitchBook data. Only $500 million in deals were struck in the first half of 2023 across 37 deals—down drastically from $44 billion for 134 deals in all of 2022.
Featured image by FG Trade/Getty Images
Learn about our editorial standards.